Vencanna Ventures Inc.

C$0.01As of Sun 8 Nov 2026, 12:00 UTC
CSE:VENIHealthcare
Country Canada
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE (165.65%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.88
PE TTM —
TSR TTM —
Mkt cap C$1.113M
ROIC (40.76%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.0048
(3.79%)
(94.43%)
Hold 3|2|7|11|4
2Q26
3Q26
4Q26
1Q27
Earnings per share$
—
—
—
—
11.72%
26.27%
29.16%
16.16%
Revenue$M
0.060
0.062
0.062
0.061
4.87%
4.66%
5.15%
(1.98%)
Peers (US$0.788M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
1.207
0.032
0.030
EBIT/Intx
1.994
0.291
0.313
Own earn%
37.75
130.69
95.64
Sh yield%
31.10
39.03
38.96
Owners
Insiders/Inst%
3.51
39.47
Short interest%
2.85
SBC / revenue%
4.23
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
4–10
$1 testx
—
Incr. ROIC%
0